Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein

We investigated how overexpression of human TATA-box-binding protein (TBP) affects the action of estrogen receptor (ER) and compared the response with that of other activators. When ER activates a simple promoter, consisting of a response element and either the collagenase or tk TATA box, TBP overexpression potentiates transcription. TBP potentiates only estrogen-induced and not basal transcription and does so independent of spacing between response element and TATA box. TBP overexpression also reduces autoinhibition by overexpressed ER, suggesting that one target of the autoinhibition may be TBP itself. Both AF-1 and AF-2 domains of ER are potentiated by TBP, and each domain binds TBP in vitro. Like ER, chimeric GAL4/VP16 and GAL4/Tat activators are also potentiated by TBP, as is the synergistic activation by ER and GAL4/VP16 on a complex promoter. Unlike ER, GAL4/Sp1 and GAL4/NF-I become less potent when TBP is overexpressed. Furthermore, synergy between ER and Sp1 or between ER and NF-I, whether these are supplied by transfected GAL4 fusions or by the endogenous genes, is inhibited by TBP overexpression. Thus, ER resembles VP16 in response to TBP overexpression and is different from Sp1 and NF-I, which predominate over ER in setting the response on complex promoters.

[1]  M. Parker,et al.  Interaction of proteins with transcriptionally active estrogen receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  X. Jacq,et al.  Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor , 1994, Cell.

[3]  R. Tjian,et al.  Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators , 1994, Cell.

[4]  Andrew J. Bannister,et al.  c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding protein , 1994, Molecular and cellular biology.

[5]  T. Kouzarides,et al.  A C‐terminal domain in FosB, absent in FosB/SF and Fra‐1, which is able to interact with the TATA binding protein, is required for altered cell growth. , 1994, The EMBO journal.

[6]  G. Martin,et al.  Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. , 1994, Science.

[7]  Tom Maniatis,et al.  Transcriptional activation: A complex puzzle with few easy pieces , 1994, Cell.

[8]  J. Baxter,et al.  Eukaryotic regulatory elements lurking in plasmid DNA: the activator protein-1 site in pUC. , 1994, Molecular endocrinology.

[9]  F. Kashanchi,et al.  Direct interaction of human TFIID with the HIV-1 transactivator Tat , 1994, Nature.

[10]  R. Tjian,et al.  A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Yaniv,et al.  Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. , 1994, The EMBO journal.

[12]  Michael R. Green,et al.  Eukaryotic activators function during multiple steps of preinitiation complex assembly , 1993, Nature.

[13]  B. Peterlin,et al.  Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. , 1993, Journal of molecular biology.

[14]  R. Tjian,et al.  Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB , 1993, Cell.

[15]  R. Rousset,et al.  Functional and biochemical interaction of the HTLV‐I Tax1 transactivator with TBP. , 1993, The EMBO journal.

[16]  C. Gélinas,et al.  Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB , 1993, Molecular and cellular biology.

[17]  G. Vriend,et al.  Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells , 1993, Nature.

[18]  Steven Hahn,et al.  Crystal structure of a yeast TBP/TATA-box complex , 1993, Nature.

[19]  Stephen K. Burley,et al.  Co-crystal structure of TBP recognizing the minor groove of a TATA element , 1993, Nature.

[20]  Qiang Zhou,et al.  Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB , 1993, Nature.

[21]  A. Berk,et al.  Functional interaction of adenovirus E1A with holo-TFIID. , 1993, Genes & development.

[22]  J. Baxter,et al.  Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site , 1993, Molecular and cellular biology.

[23]  Andrew J. Bannister,et al.  The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Chambon,et al.  Distinct TFIID complexes mediate the effect of different transcriptional activators. , 1993, The EMBO journal.

[25]  R. Tjian,et al.  Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators , 1993, Cell.

[26]  Jun Wu,et al.  Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL- VP16 and the two nonacidic activation functions of the estrogen receptor , 1993, Nucleic Acids Res..

[27]  Y. Gluzman,et al.  Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites , 1993, Journal of virology.

[28]  A. Hoffmann,et al.  Crystal structure of TFIID TATA-box binding protein , 1992, Nature.

[29]  Qiang Zhou,et al.  Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter. , 1992, Genes & development.

[30]  B. O’Malley,et al.  Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). , 1992, The Journal of biological chemistry.

[31]  P. Herrlich,et al.  Interference between pathway‐specific transcription factors: glucocorticoids antagonize phorbol ester‐induced AP‐1 activity without altering AP‐1 site occupation in vivo. , 1992, The EMBO journal.

[32]  M. Horikoshi,et al.  Cooperativity in transactivation between retinoic acid receptor and TFIID requires an activity analogous to E1A , 1992, Cell.

[33]  J. Lees,et al.  Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.

[34]  J. Baxter,et al.  The core promoter region of the tumor necrosis factor alpha gene confers phorbol ester responsiveness to upstream transcriptional activators. , 1992, Molecular and cellular biology.

[35]  J. Baxter,et al.  The limits of the cellular capacity to mediate an estrogen response. , 1992, Molecular endocrinology.

[36]  J. Manley,et al.  TFIID can be rate limiting in vivo for TATA-containing, but not TATA-lacking, RNA polymerase II promoters. , 1992, Genes & development.

[37]  R. Tjian,et al.  Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. , 1991, Genes & development.

[38]  A. Berk,et al.  Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor , 1991, Cell.

[39]  R. Tjian,et al.  Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation , 1991, Cell.

[40]  D. Reinberg,et al.  Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Shales,et al.  Reduced binding of TFIID to transcriptionally compromised mutants of VP16 , 1991, Nature.

[42]  J. Baxter,et al.  Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor alpha gene. , 1991, The Journal of biological chemistry.

[43]  J. Shine,et al.  Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. , 1990, Molecular endocrinology.

[44]  Kevin Gaston,et al.  Stringent spacing requirements for transcription activation by CRP , 1990, Cell.

[45]  Michael R. Green,et al.  Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets , 1990, Nature.

[46]  J. White,et al.  Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements. , 1990, The EMBO journal.

[47]  R. Tjian,et al.  Functional domains and upstream activation properties of cloned human TATA binding protein. , 1990, Science.

[48]  C. Ingles,et al.  Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID , 1990, Nature.

[49]  N. Webster,et al.  The human estrogen receptor has two independent nonacidic transcriptional activation functions , 1989, Cell.

[50]  P. Chambon,et al.  The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. , 1989, The EMBO journal.

[51]  P. Chambon,et al.  Steroid hormone receptors compete for factors that mediate their enhancer function , 1989, Cell.

[52]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[53]  Mark Ptashne,et al.  Negative effect of the transcriptional activator GAL4 , 1988, Nature.

[54]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[55]  P. Chambon,et al.  Functional domains of the human estrogen receptor , 1987, Cell.

[56]  C. Morency,et al.  A novel rapid assay for chloramphenicol acetyltransferase gene expression , 1987 .

[57]  Robert Tjian,et al.  Transcriptional selectivity of viral genes in mammalian cells , 1986, Cell.

[58]  D. Zava,et al.  A simple method to determine whole cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer culture. , 1984, Journal of steroid biochemistry.

[59]  D. Reinberg,et al.  Initiation of transcription by RNA polymerase II: a multi-step process. , 1993, Progress in nucleic acid research and molecular biology.